The Childhood Cancer Survivor Study genome-wide association study (GWAS) dataset is available to investigate the role of genetic susceptibility in the development of non-malignant treatment-related outcomes (in addition to subsequent malignancies) in cancer survivors. This process is open to investigators through collaboration with CCSS and National Cancer Institute investigators in the use of existing GWAS data and corresponding outcomes-related data to address innovative research questions relating to potential genetic contributions to risk for treatment-related outcomes through submission of an Application of Intent. The links below will guide you in submitting a proposal.